Vous êtes ici

Albert Labs International Corp.

Albert Labs Logo
Liste d'échange: 
CSE
Statut: 
Suspended
Industrie: 
Life Sciences
Symbole: 
ABRT
Indice CSE: 
Devise: 

Albert Labs International Corp. is a clinical research and laboratory-based drug development company serving the needs of mental health care. Through a succinct, real-world evidence (RWE)-driven clinical journey, Albert Labs seeks to commercialize its psychedelic-based treatments and, in doing so, bring psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access and faster approvals, Albert Labs prioritizes patients with urgent and unmet needs by developing licensed drugs to treat a variety of mental health conditions. Cancer-related distress, an original goal of Albert Labs' development program, is thought to affect more than 16 million patients worldwide.

Vous êtes ici

Albert Labs International Corp. (ABRT)

SEDAR Information

Information d'entreprise

Addresse
#201 - 6996 Merritt Avenue
Burnaby, BC V5J 4R6
Canada
Téléphone
(778) 819 0740
Courriel
info@albertlabs.com
URL
https://www.albertlabs.com
Date d’inscription à la cote
Mardi, septembre 6, 2011
Agent de transfert
Computershare Investor Services Inc.

Capitalisation

Capitalisation: 
74413267
Réservé à l'émission: 
11985000

Communiqués de presse

Bulletins

16/07/2024

2024-0717 - Suspensions - ABRT, JUVA, LITE, VSBY, VSBY.WT.B

le 16 juillet/July 2024

Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.